These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32041760)
1. Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome. Cheemalavagu S; McCoy SS; Knight JS BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32041760 [TBL] [Abstract][Full Text] [Related]
2. Positive antiphospholipid antibodies and pulmonary embolism in a patient with adalimumab-induced lupus. Uehara M; Matsushita S; Aochi S; Yamamoto M Mod Rheumatol Case Rep; 2023 Jan; 7(1):68-73. PubMed ID: 36208152 [TBL] [Abstract][Full Text] [Related]
3. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Ramos-Casals M; Brito-Zerón P; Muñoz S; Soria N; Galiana D; Bertolaccini L; Cuadrado MJ; Khamashta MA Medicine (Baltimore); 2007 Jul; 86(4):242-251. PubMed ID: 17632266 [TBL] [Abstract][Full Text] [Related]
4. Adalimumab-associated antiphospholipid syndrome: a case report and review of the literature. Hemmati I; Kur J Clin Rheumatol; 2013 Jul; 32(7):1095-8. PubMed ID: 23559388 [TBL] [Abstract][Full Text] [Related]
5. The management of thrombosis in the antiphospholipid-antibody syndrome. Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428 [TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab. Martín Varas C; Heras M; Saiz A; Coloma R; Calle L; Callejas R; Molina Á; Rodríguez MA; Fernández-Reyes Luis MJ Nefrologia; 2017; 37(5):560-561. PubMed ID: 28946973 [No Abstract] [Full Text] [Related]
14. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease. Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930 [TBL] [Abstract][Full Text] [Related]
15. Adalimumab-induced lupus erythematosus with central nervous system involvement in a patient with Crohn's disease. Vannucchi V; Grazzini M; Pieralli F; Giannotta M; Biagioni C; Nozzoli C J Gastrointestin Liver Dis; 2011 Jun; 20(2):201-3. PubMed ID: 21725519 [TBL] [Abstract][Full Text] [Related]
17. Severe myalgia associated with adalimumab treatment in a patient with Crohn's disease. Hinojosa J; Borrás-Blasco J; Maroto N; Rosique-Robles JD; Alos R; Casterá ME Ann Pharmacother; 2008 Jul; 42(7):1130-3. PubMed ID: 18492783 [TBL] [Abstract][Full Text] [Related]
18. Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review. Cesarini M; Angelucci E; Foglietta T; Vernia P J Crohns Colitis; 2011 Dec; 5(6):619-22. PubMed ID: 22115384 [TBL] [Abstract][Full Text] [Related]
19. Periappendicitis during adalimumab treatment for ileocecal Crohn's disease in a 29-year-old male. Mizuno S; Nakazawa A; Ogawa A; Hisamatsu T; Hirose S; Tsukada N Clin J Gastroenterol; 2015 Jun; 8(3):134-7. PubMed ID: 26023062 [TBL] [Abstract][Full Text] [Related]
20. Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn's Disease. Cankurtaran E; Ekiz F; Hamamci M; Akinci H; Coskun Y; Yuksel I Dig Dis Sci; 2016 Apr; 61(4):1206-7. PubMed ID: 26894400 [No Abstract] [Full Text] [Related] [Next] [New Search]